Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of CBD TPM Capsules in Adults for Use in the Reduction of Insomnia Severity

NCT05840822 is registered in ClinicalTrials.gov with Avecho Biotechnology as lead sponsor.

NCT NCT05840822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05840822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of CBD TPM Capsules in Adults for Use in the Reduction of Insomnia Severity
Lead sponsor
Avecho Biotechnology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 16, 2024
Completion date
December 31, 2027
Enrollment
519 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia